|
Canada-0-Automobile Undercoating Rust Κατάλογοι Εταιρεία
|
Εταιρικά Νέα :
- Management of moderate and severe alcohol withdrawal syndromes
The inpatient management of syndromes associated with moderate and severe alcohol withdrawal is reviewed here The ambulatory management of mild alcohol withdrawal, the initial diagnosis and treatment of alcohol use disorder, and specific conditions due to alcohol-related organ damage (eg, cirrhosis, pancreatitis) are discussed separately
- Alcohol withdrawal: Ambulatory management - UpToDate
Provides guidance on ambulatory management of alcohol withdrawal, focusing on alleviating symptoms and preparing for the maintenance phase of treatment
- Management of moderate and severe alcohol withdrawal syndromes
The inpatient management of syndromes associated with moderate and severe alcohol withdrawal is reviewed here The ambulatory management of mild alcohol withdrawal, the initial diagnosis and treatment of alcohol use disorder, and specific conditions due to alcohol-related organ damage (eg, cirrhosis, pancreatitis) are discussed separately
- Medline ® Abstract for Reference 63 of Management of moderate and . . .
The primary outcomes that were the focus of our study consisted of changes in the length of hospital stay, length of ICU stay, and changes in scoring systems (for alcohol withdrawal assessment and monitoring) following the implementation of phenobarbital The secondary outcomes included complications such as intubation and mortality
- Management of moderate and severe alcohol withdrawal syndromes
The best predictor for clinically significant alcohol withdrawal is a score of 4 or higher on the Prediction of Alcohol Withdrawal Severity Scale (PAWSS) (table 2) Initial treatment and stabilization – Patients in alcohol withdrawal require medical treatment and observation
- Alcohol use disorder: Pharmacologic management - UpToDate
Explore pharmacologic management strategies for alcohol use disorder, including treatment options and outcomes, on this comprehensive resource
- Medline ® Abstract for Reference 62 of Management of moderate and . . .
Epub 2025 Mar 28 BackgroundThis study directly compares outcomes of phenobarbital and dexmedetomidine as adjuncts to symptom-triggered benzodiazepine treatment for alcohol withdrawal syndrome (AWS) MethodsThis is a retrospective cohort analysis at a single tertiary referral institution in a major urban center in the United States
- Management of moderate and severe alcohol withdrawal syndromes
The inpatient management of syndromes associated with moderate and severe alcohol withdrawal is reviewed here The ambulatory management of mild alcohol withdrawal, the initial diagnosis and treatment of alcohol use disorder, and specific conditions due to alcohol-related organ damage (eg, cirrhosis, pancreatitis) are discussed separately
- Management of moderate and severe alcohol withdrawal syndromes
(See 'Refractory delirium tremens, including use of phenobarbital' above ) Asymptomatic patients at risk for withdrawal – Asymptomatic or minimally symptomatic patients at risk for alcohol withdrawal but admitted to the hospital for other reasons should be closely monitored and may be treated prophylactically with oral benzodiazepines
- Medline ® Abstract for Reference 64 of Management of moderate and . . .
Epub 2024 Jan 8 OBJECTIVE Despite frequent treatment of alcohol withdrawal syndrome (AWS) in the emergency department (ED), evidence for phenobarbital (PB) as an ED alternative therapy is mixed We conducted a systematic review and meta-analysis comparing safety and efficacy of PB to benzodiazepines (BZDs) for treatment of AWS in the ED
|
|